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Abstract
Background: As the specialty of Andrology expands it is important to establish the most important studies that
have shaped, and continue to shape, current research and clinical practice. Bibliometric analysis involving a citation
rank list is an established means by which to identify the published material within a given field that has greatest
intellectual influence. This bibliometric analysis sought to identify the 100 most influential manuscripts in Andrology,
as well as the key research themes that have shaped contemporary understanding and management of andrological
conditions.
Methods: The Thompson Reuters Web of Science citation indexing database was interrogated using a number of
search terms chosen to reflect the full spectrum of andrological practice. Results were ranked according to citation
number and further analysed according to subject, first and senior author, journal, year of publication, institution and
country of origin.
Results: The Web of Science search returned a total of 24,128 manuscripts. Citation number of the top 100 articles
ranged from 2819 to 218 (median 320). The most cited manuscript (by Feldman et al., The Journal of Urology 1994;
2819 citations) reported the prevalence and risk factors for erectile dysfunction (ED) in the Massachusetts Male Ageing
Study. The Journal of Urology published the highest number of manuscripts (n = 11), followed by the New England
Journal of Medicine (n = 10). The most common theme represented within the top 100 manuscripts was erectile
dysfunction (n = 46), followed jointly by hypogonadism and male factor infertility (n = 24 respectively).
Conclusion: Erectile dysfunction should be considered the most widely researched, published and cited field within
andrological practice. This study provides a list of the most influential manuscripts in andrology and serves as a
reference of what comprises a ‘highly citable’ paper for both researchers and clinicians.
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Résumé
Contexte: Etant donné que la spécialité Andrologie se développe, il est important de dresser un inventaire des
études les plus importantes qui ont façonné, et qui continuent à façonner, la recherche actuelle et la pratique clinique.
L’analyse bibliométrique, qui inclue une liste de rang de citations, est un moyen bien établi pour identifier le matériel
publié, dans un champ donné, qui a la plus grande influence intellectuelle. La présente analyse bibliométrique cherche
à identifier les 100 manuscrits les plus influents en Andrologie, ainsi que les principaux thèmes de recherche qui ont
façonné la compréhension et la prise en charge contemporaines des situations andrologiques.
Méthodes: La base de données d’indexation des citations du Web of Science de Thompson Reuters a été interrogée
en utilisant un nombre de termes de recherche choisis pour refléter l’éventail complet de la pratique andrologique.
Les résultats ont été classés selon leur nombre de citations, puis ensuite analysés en fonction du sujet, des premier et
dernier auteurs, du journal, de l’année de publication, de l’institution et du pays d’origine.
Résultats: La recherche sur le Web of Science a rapporté un total de 24 128 manuscrits. Le nombre de citations des
100 premiers articles va de 2 819 à 218 (médiane 320). L’article le plus cité (de Feldman et al., The Journal of Urology
1994 ; 2 819 citations) rapportait la prévalence et les facteurs de risque de la dysfonction érectile (DE) dans l’étude du
Massachusetts menée chez l’homme vieillissant. The Journal of Urology a publié le plus grand nombre de manuscrits
(n=11), suivi du New England Journal of Medicine (n=10). Le thème le plus souvent représenté dans les manuscrits du
top 100 était la dysfonction érectile (n=46), suivi conjointement par l’hypogonadisme et l’infertilité d’origine masculine
(respectivement n=24).
Conclusion: La dysfonction érectile devrait être considérée comme le champ de la pratique andrologique qui a le plus
largement fait l’objet de recherches, de publications et de citations. La présente étude fournit une liste des manuscrits
les plus influents en andrologie, et constitue une référence sur ce que signifie un article ‘fortement cité’ à la fois pour
les chercheurs et pour les cliniciens.
Background
Andrology is the medical specialty that focuses on many
aspects of male health, comprising a wide range of con-
ditions of the male reproductive system, as well as uro-
logical pathologies that are specific to men. Although
the clinical science had been studied for many years, it
was not until after the introduction of the term ‘androl-
ogy’ in 1951 that scientists and clinicians from a diverse
range of backgrounds began to refer to themselves as
‘andrologists’ [1]. Since then the discipline has continued
to evolve, with the introduction of national and inter-
national societies, recognised and accredited training
courses and a number of high quality dedicated journals.
In the present day, andrologists are involved in the man-
agement of a wide spectrum of diseases ranging from
male factor infertility through to hypogonadism and
penile cancer. As the specialty grows and the body of lit-
erature focusing on andrological topics expands it is im-
portant to establish the most important and influential
manuscripts that have shaped, and continue to shape,
current research and clinical practice.
The generation of a citation rank list is one method of
identifying the published material within a given field
that has greatest intellectual influence [2]. A citation re-
fers to the referencing of an article by another
peer-reviewed publication. It is therefore probable that
articles which have the greatest impact on the scientific
and clinical communities are cited many times more
than those which have had little impact. Citation analysis
is the process of ranking the most frequently cited arti-
cles in order to produce a citation rank list. In addition,
citation numbers can be used to rank journals through
calculation of their ‘impact factor.’ This is a measure of
the average number of citations a manuscript published
in a particular journal received during a specific time-
frame and is often used a surrogate marker for journal
quality.
A number of clinical disciplines have employed cit-
ation analysis to determine the most influential articles
in their field. These include entire specialties such as
general surgery [3], plastic surgery [4] and orthopaedic
surgery [5], as well as subspecialties such as laparoscopic
and emergency abdominal surgery [6, 7]. Whilst citation
analysis has been conducted within urology as a whole
[8, 9], and more specifically for male factor infertility
[10], no study to date has been undertaken to determine
the most influential manuscripts in andrology. This
bibliometric analysis therefore aimed to identify the
most influential articles in the field, as well as key re-
search themes that have been instrumental in developing
our contemporary understanding and management of
andrological conditions.
Methods
The Thompson Reuters Web of Science citation index-
ing database was interrogated using the method
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Table 1 The 100 most cited manuscripts in Andrology
Rank Manuscript (first author, title, journal and year) Citations
1 Feldman HA. Impotence and its medical and psychosocial correlates - results of the Massachusetts male aging
study. Journal of Urology 1994.
2819
2 Rosen RC. The international index of erectile function (IIEF): A multidimensional scale for assessment of erectile
dysfunction. Urology 1997.
2480
3 Goldstein I. Oral sildenafil in the treatment of erectile dysfunction. New England Journal of Medicine 1998. 1515
4 Rosen RC. Development and evaluation of an abridged, 5-item version of the International Index of Erectile Func-
tion (IIEF-5) as a diagnostic tool for erectile dysfunction. International Journal of Impotence Research 1999.
1325
5 Droller MJ. Impotence: NIH consensus development panel on impotence. Journal of the American Medical
Association 1993.
1270
6 de Roux N. Hypogonadotropic hypogonadism due to loss of function of the KiSS1-derived peptide receptor
GPR54. Proceedings of the National Academy of Sciences of the United States of America 2003.
1237
7 Walsh PC. Impotence following radical prostatectomy - insight into etiology and prevention. Journal of Urology
1982.
1044
8 Lue TF. Drug therapy: Erectile dysfunction. New England Journal of Medicine 2000. 793
9 Rosen R. Lower urinary tract symptoms and male sexual dysfunction: The multinational survey of the aging male
(MSAM-7). European Urology 2003.
675
10 Evenson DP. Sperm chromatin structure assay: Its clinical use for detecting sperm DNA fragmentation in male
infertility and comparisons with other techniques. Journal of Andrology 2002.
610
11 Eddy EM. Targeted disruption of the estrogen receptor gene in male mice causes alteration of spermatogenesis
and infertility. Endocrinology 1996.
607
12 Johannes CB. Incidence of erectile dysfunction in men 40 to 69 years old: Longitudinal results from the
Massachusetts male aging study. Journal of Urology 2000.
558
13 Aytac IA. The likely worldwide increase in erectile dysfunction between 1995 and 2025 and some possible policy
consequences. British Journal of Urology International 1999.
553
14 Muscatelli F. Mutations in the dax-1 gene give rise to both x-linked adrenal hypoplasia congenita and hypogona-
dotropic hypogonadism. Nature 1994.
536
15 Wu FCW. Identification of Late-Onset Hypogonadism in Middle-Aged and Elderly Men. New England Journal of
Medicine 2010.
524
16 Katznelson L. Increase in bone density and lean body mass during testosterone administration in men with
acquired hypogonadism. Journal of Clinical Endocrinology & Metabolism 1996.
516
17 Sharma RK. Role of reactive oxygen species in male infertility. Urology 1996. 516
18 Braun M. Epidemiology of erectile dysfunction: results of the ‘Cologne Male Survey’. International Journal of
Impotence Research 2000.
511
19 Mason AJ. A deletion truncating the gonadotropin-releasing-hormone gene is responsible for hypogonadism in
the hpg mouse. Science 1986.
492
20 Krane RJ. Impotence. New England Journal of Medicine 1989. 482
21 Thompson IM. Erectile dysfunction and subsequent cardiovascular disease. Journal of the American Medical
Association 2005.
481
22 Tremellen K. Oxidative stress and male infertility-a clinical perspective. Human Reproduction Update 2008. 479
23 Lue TF. Physiology of erection and pharmacological management of impotence. Journal of Urology 1987. 458
24 Cattanach BM. Gonadotrophin-releasing hormone deficiency in a mutant mouse with hypogonadism. Nature 1977. 453
25 de Tejada IS. Impaired neurogenic and endothelium-mediated relaxation of penile smooth-muscle from diabetic
men with impotence. New England Journal of Medicine 1989.
438
26 Esposito K. Effect of lifestyle changes on erectile dysfunction in obese men - A randomized controlled trial. Journal
of the American Medical Association 2004.
434
27 Feldman HA. Erectile dysfunction and coronary risk factors: Prospective results from the Massachusetts Male Aging
Study. Preventive Medicine 2000.
431
28 Boolell M. Sildenafil, a novel effective oral therapy for male erectile dysfunction. British Journal of Urology 1996. 423
29 Terrett NK. Sildenafil (VIAGRA), a potent and selective inhibitor of type 5 cGMP phosphodiesterase with utility for
the treatment of male erectile dysfunction. Bioorganic & Medicinal Chemistry Letters 1996.
421
30 Thorner MO. Long-term treatment of galactorrhea and hypogonadism with bromocriptine. British Medical Journal
1974.
421
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Table 1 The 100 most cited manuscripts in Andrology (Continued)
Rank Manuscript (first author, title, journal and year) Citations
31 Hatzimouratidis K. Guidelines on Male Sexual Dysfunction: Erectile Dysfunction and Premature Ejaculation.
European Urology 2010.
420
32 Dubin L. Etiologic factors in 1294 consecutive cases of male infertility. Fertility and Sterility 1971. 418
33 Rendell MS. Sildenafil for treatment of erectile dysfunction in men with diabetes - A randomized controlled trial.
Journal of the American Medical Association 1999.
417
34 Tut TG. Long polyglutamine tracts in the androgen receptor are associated with reduced trans-activation, impaired
sperm production, and male infertility. Journal of Clinical Endocrinology & Metabolism 1997.
416
35 Carter JN. Prolactin-secreting tumors and hypogonadism in 22 men. New England Journal of Medicine 1978. 414
36 Whorton D. Infertility in male pesticide workers. Lancet 1977. 405
37 Topaloglu AK. TAC3 and TACR3 mutations in familial hypogonadotropic hypogonadism reveal a key role for
Neurokinin B in the central control of reproduction. Nature Genetics 2009.
395
38 Dix DJ. Targeted gene disruption of Hsp70–2 results in failed meiosis, germ cell apoptosis, and male infertility.
Proceedings of the National Academy of Sciences of the United States of America 1996.
393
39 Agarwal A. Role of sperm chromatin abnormalities and DNA damage in male infertility. Human Reproduction
Update 2003.
389
40 Brindley GS. Cavernosal alpha-blockade - a new technique for investigating and treating erectile impotence. British
Journal of Psychiatry 1983.
374
41 Padma-Nathan H. Treatment of men with erectile dysfunction with transurethral alprostadil. New England Journal
of Medicine 1997.
354
42 Morales A. Clinical safety of oral sildenafil citrate (VIAGRA) in the treatment of erectile dysfunction. International
Journal of Impotence Research 1998.
351
43 Virag R. Is impotence an arterial disorder - a study of arterial risk-factors in 440 impotent men. Lancet 1985. 349
44 Araujo AB. The relationship between depressive symptoms and male erectile dysfunction: Cross-sectional results
from the Massachusetts Male Aging Study. Psychosomatic Medicine 1998.
345
45 Montorsi F. Erectile dysfunction prevalence, time of onset and association with risk factors in 300 consecutive
patients with acute chest pain and angiographically documented coronary artery disease. European Urology 2003.
340
46 Mulligan T. Prevalence of hypogonadism in males aged at least 45 years: the HIM study. International Journal of
Clinical Practice 2006.
331
47 Oliva R. Protamines and male infertility. Human Reproduction Update 2006. 330
48 Brock GB. Efficacy and safety of tadalafil for the treatment of erectile dysfunction: Results of integrated analyses.
Journal of Urology 2002.
330
49 Dhindsa S. Frequent occurrence of hypogonadotropic hypogonadism in type 2 diabetes. Journal of Clinical
Endocrinology & Metabolism 2004.
327
50 Roth JC. FSH and LH response to luteinizing hormone-releasing factor in prepubertal and pubertal children, adult
males and patients with hypogonadotropic and hypergonadotropic hypogonadism. Journal of Clinical Endocrin-
ology & Metabolism 1972.
321
51 Zorgniotti AW. Auto-injection of the corpus cavernosum with a vasoactive drug-combination for vasculogenic im-
potence. Journal of Urology 1985.
319
52 de Roux N. A family with hypogonadotropic hypogonadism and mutations in the gonadotropin-releasing hor-
mone receptor. New England Journal of Medicine 1997.
314
53 Martin-Morales A. Prevalence and independent risk factors for erectile dysfunction in Spain: Results of the
Epidemiologia de la Disfuncion Erectil Masculina study. Journal of Urology 2001.
308
54 Saleh RA. Oxidative stress and male infertility: From research bench to clinical practice. Journal of Andrology 2002. 307
55 Derby CA. Modifiable risk factors and erectile dysfunction: Can lifestyle changes modify risk? Urology 2000. 301
56 Linet OI. Efficacy and safety of intracavernosal alprostadil in men with erectile dysfunction. New England Journal of
Medicine 1996.
300
57 Agarwal A. Clinical relevance of oxidative stress in male factor infertility: An update. American Journal of
Reproductive Immunology 2008.
299
58 Lue TF. Vasculogenic impotence evaluated by high-resolution ultrasonography and pulsed doppler spectrum ana-
lysis. Radiology 1985.
298
59 Rosen RC. The multinational Men’s Attitudes to Life Events and Sexuality (MALES) study: I. Prevalence of erectile
dysfunction and related health concerns in the general population. Current Medical Research and Opinion 2004.
297
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Table 1 The 100 most cited manuscripts in Andrology (Continued)
Rank Manuscript (first author, title, journal and year) Citations
60 Finkelstein JS. Osteoporosis in men with idiopathic hypogonadotropic hypogonadism. Annals of Internal Medicine
1987.
295
61 Kodama H. Increased oxidative deoxyribonucleic acid damage in the spermatozoa of infertile male patients.
Fertility and Sterility 1997.
293
62 Lapatto R. Kiss1(−/−) mice exhibit more variable hypogonadism than Gpr54(−/−) mice. Endocrinology 2007. 291
63 Smith JC. The effects of induced hypogonadism on arterial stiffness, body composition, and metabolic parameters
in males with prostate cancer. Journal of Clinical Endocrinology & Metabolism 2001.
288
64 McCulloch DK. The prevalence of diabetic impotence. Diabetologia 1980. 287
65 Debraekeleer M. Cytogenetic studies in male-infertility - a review. Human Reproduction 1991. 277
66 Selvin E. Prevalence and risk factors for erectile dysfunction in the US. American Journal of Medicine 2007. 276
67 Mulryan K. Reduced vas deferens contraction and male infertility in mice lacking P2X(1) receptors. Nature 2000. 275
68 Solomon H. Erectile dysfunction and the cardiovascular patient: endothelial dysfunction is the common
denominator. Heart 2003.
270
69 Hendren SK. Prevalence of male and female sexual dysfunction is high following surgery for rectal cancer. Annals
of Surgery 2005.
269
70 Finkelstein JS. Increases in bone-density during treatment of men with idiopathic hypogonadotropic hypogonad-
ism. Journal of Clinical Endocrinology & Metabolism 1989.
269
71 Chang CS. Infertility with defective spermatogenesis and hypotestosteronemia in male mice lacking the androgen
receptor in Sertoli cells. Proceedings of the National Academy of Sciences of the United States of America 2004.
258
72 Wang C. Investigation, treatment and monitoring of late-onset hypogonadism in males. European Journal of Endo-
crinology 2008.
256
73 Weiss J. Hypogonadism caused by a single amino-acid substitution in the beta subunit of luteinizing-hormone.
New England Journal of Medicine 1992.
254
74 Kaiser DR. Impaired brachial artery endothelium-dependent and -independent vasodilation in men with erectile
dysfunction and no other clinical cardiovascular disease. Journal of the American College of Cardiology 2004.
253
75 Ellenber M. Impotence in diabetes - neurologic factor. Annals of Internal Medicine 1971. 249
76 Althof SE. EDITS: Development of questionnaires for evaluating satisfaction with treatments for erectile dysfunction.
Urology 1999.
247
77 Slag MF. Impotence in medical clinic outpatients. Journal of the American Medical Association 1983. 246
78 Kapoor D. Clinical and biochemical assessment of hypogonadism in men with type 2 diabetes: Correlations with
bioavailable testosterone and visceral adiposity. Diabetes Care 2007.
244
79 Maden C. History of circumcision, medical conditions, and sexual-activity and risk of penile cancer. Journal of the
National Cancer Institute 1993.
243
80 Palermo GD. Intracytoplasmic sperm injection - a novel treatment for all forms of male factor infertility. Fertility and
Sterility 1995.
242
81 Woolf PD. Transient hypogonadotropic hypogonadism caused by critical illness. Journal of Clinical Endocrinology &
Metabolism 1985.
242
82 Ghofrani HA. Sildenafil: from angina to erectile dysfunction to pulmonary hypertension and beyond. Nature
Reviews Drug Discovery 2006.
240
83 Nicolosi A. Epidemiology of erectile dysfunction in four countries: Cross-national study of the prevalence and corre-
lates of erectile dysfunction. Urology 2003.
240
84 Bivalacqua TJ. RhoA/Rho-kinase suppresses endothelial nitric oxide synthase in the penis: A mechanism for
diabetes-associated erectile dysfunction. Proceedings of the National Academy of Sciences of the United States of
America 2004.
239
85 de Kretser DM. Male infertility. Lancet 1997. 239
86 Macleod J. The male factor in fertility and infertility .2. Spermatozoon counts in 1000 men of known fertility and in
1000 cases of infertile marriage. Journal of Urology 1951.
239
87 Sharma RK. The reactive oxygen species - total antioxidant capacity score is a new measure of oxidative stress to
predict male infertility. Human Reproduction 1999.
238
88 McVary KT. Sildenafil citrate improves erectile function and urinary symptoms in men with erectile dysfunction and
lower urinary tract symptoms associated with benign prostatic hyperplasia: A randomized, double-blind trial. Jour-
nal of Urology 2007.
235
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previously described by Ellul et al. [6]. As andrology is a
broad subspecialty that draws from a range of other dis-
ciplines, it is probable that influential articles pertaining
to relevant topics have been published in a wide array of
journals, not just those specific to urology and sexual
medicine. A number of title search terms were therefore
selected and combined to ensure all relevant
manuscripts were identified, as follows: ‘andrology’, ‘male
infertility’, ‘erectile dysfunction’, ‘impotence’, ‘penile de-
formity’, ‘penile curvature’, ‘peyronie’s disease’, ‘priapism’,
‘penile fracture’, ‘ejaculatory disorder’, ‘male sexual dys-
function’, ‘hypogonadism’, ‘penile cancer’, ‘squamous cell
carcinoma’ and ‘penis’. Truncation using the asterisk
function (*) was utilised for particular words with
Table 1 The 100 most cited manuscripts in Andrology (Continued)
Rank Manuscript (first author, title, journal and year) Citations
89 User HM. Penile weight and cell subtype specific changes in a post-radical prostatectomy model of erectile dys-
function. Journal of Urology 2003.
233
90 Seminara SB. Gonadotropin-releasing hormone deficiency in the human Idiopathic hypogonadotropic hypogonad-
ism and Kallmann’s syndrome: Pathophysiological and genetic considerations. Endocrine Reviews 1998.
233
91 Korenman SG. Secondary hypogonadism in older men - its relation to impotence. Journal of Clinical
Endocrinology & Metabolism 1990.
231
92 Talcott JA. Patient-reported impotence and incontinence after nerve-sparing radical prostatectomy. Journal of the
National Cancer Institute 1997.
229
93 Montague DK. American Urological Association guideline on the management of priapism. Journal of Urology
2003.
228
94 Marks LS. Effect of testosterone replacement therapy on prostate tissue in men with late-onset hypogonadism - A
randomized controlled trial. Journal of the American Medical Association 2006.
226
95 Benet AE. The epidemiology of erectile dysfunction. Urologic Clinics of North America 1995. 225
96 Sikka SC. Role of oxidative stress and antioxidants in male infertility. Journal of Andrology 1995. 225
97 Balhorn R. Aberrant protamine-1 protamine-2 ratios in sperm of infertile human males. Experientia 1988. 225
98 Daling JR. Penile cancer: importance of circumcision, human papillomavirus and smoking in in situ and invasive
disease. International Journal of Cancer 2005.
224
99 Cummins JM. Molecular-biology of human male-infertility - links with aging, mitochondrial genetics, and oxidative
stress. Molecular Reproduction and Development 1994.
224
100 Saleh RA. Negative effects of increased sperm DNA damage in relation to seminal oxidative stress in men with
idiopathic and male factor infertility. Fertility and Sterility 2003.
218
Fig. 1 Bar graph demonstrating the distribution of the 100 most cited articles according to the decade in which they were published
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multiple relevant variations, for example the term ‘peni*’
was used to capture both ‘penis’ and ‘penile’. These
search terms were chosen to reflect the core topics pub-
lished in the European Academy of Andrology-European
Society of Andrological Urology Joint Educational Cur-
riculum for Clinical Andrology Training in Europe [11].
The search was conducted on 5th June 2018 and in-
cluded all manuscripts published in the English language
from 1900 onwards. Results were subsequently ranked
by citation number. Final interrogation of the database
was independently performed by two assessors (NB and
TE). The 100 most cited articles were further evaluated
according to subject, first and senior author, journal,
year of publication, institution and country of origin.
The 2016 impact factor of each journal was also identi-
fied from the Journal Citation Reports dataset [12]. In
order to adjust for older articles accruing a higher num-
ber of citations over time the citation rate was calculated
by dividing the number of citations by the number of
years since publication. Articles were excluded if pub-
lished prior to 1900, in languages other than English
and/or if, after independent assessment by two re-
searchers, it was agreed the main focus was not directly
relevant to the field andrology. In cases of disagreement
on the suitability for inclusion, the manuscript in ques-
tion was discussed by both assessors and a consensus
decision reached.
Table 2 Journals in which the 100 most cited manuscripts were
published, ranked according to number with corresponding
impact factors at the time of review
Journal Title Impact Factor
as of 2016
Number of
Manuscripts
in Top 100
Total number
of citations
Journal of Urology 5.157 11 6771
New England Journal
of Medicine
72.406 10 5388
Journal of Clinical
Endocrinology and
Metabolism
5.455 8 2610
Journal of the American
Medical Association
44.405 6 3074
Urology 2.309 5 3784
Fertility and Sterility 4.447 4 1171
Proceedings of the National
Academy of Sciences of the
United States of America
9.661 4 2127
European Urology 16.265 3 1435
Human Reproduction
Update
11.748 3 1198
International Journal of
Impotence Research
1.293 3 2187
Journal of Andrology 2.473 3 1142
Lancet 47.831 3 993
Nature 40.137 3 1264
Annals of Internal Medicine 17.202 2 544
Endocrinology 4.286 2 898
Human Reproduction 5.02 2 515
Journal of the National
Cancer Institute
13.757 2 472
American Journal of
Medicine
5.55 1 276
American Journal of
Reproductive Immunology
3.013 1 299
Annals of Surgery 8.98 1 269
Bioorganic & Medicinal
Chemistry Letters
2.454 1 421
British Journal of Psychiatry 6.347 1 374
British Journal of Urologya 1.69 1 423
British Journal of Urology
International
4.439 1 553
British Medical Journal 17.215 1 421
Current Medical Research
and Opinion
2.757 1 297
Diabetes Care 11.857 1 244
Diabetologia 6.08 1 287
Endocrine Reviews 15.745 1 233
European Journal of
Endocrinology
4.101 1 256
Experientia 2.072 1 225
Heart 6.059 1 270
Table 2 Journals in which the 100 most cited manuscripts were
published, ranked according to number with corresponding
impact factors at the time of review (Continued)
Journal Title Impact Factor
as of 2016
Number of
Manuscripts
in Top 100
Total number
of citations
International Journal
of Cancer
6.513 1 224
International Journal
of Clinical Practice
2.14 1 331
Journal of the American
College of Cardiology
19.896 1 253
Molecular Reproduction
and Development
2.316 1 224
Nature Genetics 27.959 1 395
Nature Reviews Drug
Discovery
57 1 240
Preventive Medicine 3.434 1 431
Psychosomatic Medicine 3.863 1 345
Radiology 7.296 1 298
Science 37.205 1 492
Urologic Clinics of
North America
2.22 1 225
aImpact Factor available for 2000 only
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Results
The Web of Science search returned a total of 24,128
manuscripts. Table 1 lists the 100 most cited articles as
ranked by citation number, following application of ex-
clusion criteria. Where two articles had equal numbers
of citations, further stratification was based on citation
rate. The most cited article was that by Feldman et al.
describing the prevalence of and risk factors for erectile
dysfunction (ED) in the Massachusetts Male Ageing
Study, published in The Journal of Urology in 1994 and
has been cited 2819 times [13].
The 100 most cited manuscripts were published over a
broad time period, with the greatest proportion between
2000 and 2009 (n = 41), as demonstrated in Fig. 1. The
most historic article was that by Macleod and Gold
reporting comparative semen analysis in both ‘fertile’
and ‘infertile’ men, published in The Journal of Urology
in 1951 and cited 239 times [14]. The most recent
manuscript was that published in 2010 in European Ur-
ology by Hatzimouratidis, et al. outlining the European
Association of Urology guidelines on investigation and
management of male sexual dysfunction, which has been
cited 420 times [15].
Table 2 outlines the 43 journals in which the top
100 manuscripts were published. The Journal of
Urology (impact factor 5.157) published the highest
number (n = 11), including the most cited article by
Feldman et al. [13], and accrued a total overall
citation number of 6771. This was followed by The
New England Journal of Medicine, which published
10 manuscripts and was also the journal with the
highest impact factor (72.406).
The country with the greatest number of publications
was the United States of America (n = 66), followed by
the United Kingdom (n = 12) and Canada (n = 5). The
Massachusetts General Hospital was the institution with
the greatest number of manuscripts (n = 7), followed
jointly by the Cleveland Clinic and New England Re-
search Institute (n = 6 respectively), all of which are based
in the USA. RC Rosen [16–19] and TF Lue [20–22] were
the first authors with the highest number of manuscripts
in the top 100, achieving 4 and 3 respectively. A number
of senior authors published more than one manuscript,
with JB McKinlay achieving the greatest (n = 5), including
the most cited article [13, 23–26].
Figure 2 gives the top 100 manuscripts according to
type. The majority were original research articles (n =
77, Fig. 2a), of which 59 (76.6%) reported clinical out-
comes (based on either observational or interventional
methodology) and 18 (23.4%) reported the findings of
basic scientific work (Fig. 2b). The number of manu-
scripts pertaining to each of the main andrology themes
are given in Fig. 3a. ED was the most common (n = 46),
followed jointly by hypogonadism and male factor infer-
tility (n = 24 respectively). Figure 3b demonstrates
manuscript theme as strafitied by decade of publication.
Hypogonadism was the most common theme prior to
1980 (n = 4), after which ED remained the most
common up until 2010. Despite an overall trend of in-
creasing numbers of manuscripts focussing on ED
within the top 100 during this period, the relative pro-
portion of manuscripts fell with each decade (66.7, 47.1
and 46.3% between 1980 and 89, 1990–99 and 2000–09
respectivelty).
Fig. 2 Manuscript type. a Bar graph demonstrating composition of the 100 most cited articles according to manuscript type. b Pie chart
demonstrating the study design of the 77 original research articles
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The citation rate of the top 10 manuscripts ranged
from 118 to 45, as shown in Table 3. A number of arti-
cles from the top 10 remained the same when ranked by
citation rate, although three were replaced by the more
contemporary manuscripts by Wu, et al. (2010, 524 cita-
tions) [27], Hatzimouratidis, et al. (2010, 420 citations)
[15] and Tremellen (2008, 479 citations) [28].
Discussion
This study is the first bibliometric analysis to identify
and analyse the most influential manuscripts in the field
of andrology. A range of topics were represented within
the top 100, which reflects the spectrum of clinical
andrological practice as well as the variation in the spe-
cialist backgrounds of andrological practitioners and
researchers. Similarly, there is significant overlap with
other medical specialties including, but not limited to,
endocrinology. Despite this overlap, the most prevalent
theme of publication was the assessment and/or treatment
of patients with ED, constituting 46 papers within the top
100. This included the most cited article by Feldman, et al.
[13] describing the prevalence of, and risk factors for, ED
in the Massachusetts Male Ageing Study, published in
The Journal of Urology in 1994 and cited 2819 times. The
Massachusetts Male Aging Study was a community-based,
observational survey of non-institutionalised men between
40 and 70 years old conducted between 1987 to 1989 in
cities and towns near Boston, Massachusetts. The aim was
to correlate a self-administered erectile function question-
naire with an assessment of patients’ overall health. The
Fig. 3 Bar graph demonstrating composition of the 100 most cited articles according to theme. a overall. b stratified according to decade
of publication
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authors noted a strong correlation with patients who had
vascular, cardiac or smoking-related diseases and con-
cluded that ED was associated with potentially reversible
age-related changes.
The self-administered erectile function questionnaire
reported in the Feldman, et al. study differed from the
now more commonly used International Index of Erect-
ile Function (IIEF), which was first described three years
later in 1997 by Rosen, et al. [16]. This landmark publi-
cation constituted the second most cited article in this
bibliometric analysis. Similarly, the fourth most cited art-
icle described an updated version of the IIEF question-
naire and was again published by Rosen, et al. [17]. The
reason that these papers have been cited so frequently is
most likely due to both the high overall prevalence of
publications focussing on ED, and the fact that the
IIEF-5 is widely used in clinical practice to measure the
severity of ED and is hence frequently used in research
studies as an ‘objective’ measurement of function, treat-
ment efficacy or response.
Fourteen manuscripts in the top 100 focussed specific-
ally on the treatment of ED. These ranged in age from
the article by Brindley in 1983 examining the effects of
intra-cavernosal alpha-blockade [29], to that by McVary,
et al. in 2007 reporting the results of a randomised con-
trolled trial investigating the effects of oral sildenafil on
both ED and urinary symptoms [30]. This analysis
demonstrates that there was a significant increase in the
number of influential manuscripts focussing on the
treatment of ED following publication of the landmark
paper by Goldstein, et al. in 1998 reporting the effective-
ness of oral sildenafil [31]. This was the first paper to de-
scribe an oral treatment for ED and is the third most
cited manuscript in the top 100. Prior to this time, treat-
ments had been relatively intolerable for patients, in-
cluding vacuum tumescence devices, intracavernosal
injections of vasoactive agents, transurethral delivery of
alprostadil, and invasive surgical procedures. The avail-
ability of oral treatments for ED subsequently resulted in
a rapid increase in research being undertaken into all as-
pects of the condition, which is reflected in the numer-
ous manuscripts published after 1998 that feature in the
top 100 (Figs. 1 and 3b). Furthermore, it is probable that
there was an increase in self-reporting of ED and a drive
towards increased research funding and activity when a
number of ‘tolerable’ treatments became available.
A significant majority of manuscripts were published
by authors in the United States of America (n = 66),
followed by the United Kingdom (n = 12) and Canada
(n = 5). This disparity between the USA and other coun-
tries may reflect the subspecialisation that occurs in con-
temporary American Urological practice compared with
other geographical regions [32]. This means that clini-
cians are more likely to be solely practicing andrology,
Table 3 Top 10 manuscripts with the highest citation rate
Rank Citation Rate First Author Senior Author Title First author institution Country
1 118 Rosen RC Mishra A The international index of erectile function
(IIEF): A multidimensional scale for assessment
of erectile dysfunction
University of Medicine and
Dentistry of New Jersey
USA
2 117 Feldman HA McKinlay JB Impotence and its medical and psychosocial
correlates - results of the Massachusetts male
aging study
New England Research Institute USA
3 82 de Roux N Milgrom E Hypogonadotropic hypogonadism due to loss
of function of the KiSS1-derived peptide
receptor GPR54
Hôpital de Bicêtre France
4 76 Goldstein I Wicker PA Oral sildenafil in the treatment of erectile
dysfunction
Boston University Medical Centre USA
5 70 Rosen RC Pena BM Development and evaluation of an abridged,
5-item version of the International Index of
Erectile Function (IIEF-5) as a diagnostic tool
for erectile dysfunction
Robert Wood Johnson Medical
School
USA
6 66 Wu FCW Huhtaniemi IT Identification of Late-Onset Hypogonadism in
Middle-Aged and Elderly Men
University of Manchester UK
7 53 Hatzimouratidis K Wespes E Guidelines on Male Sexual Dysfunction:
Erectile Dysfunction and Premature Ejaculation
Aristotle University of Thessaloniki Greece
8 51 Droller MJ Hall WH Impotence: NIH consensus development
panel on impotence
Mount Sinai Medical Center USA
9 48 Tremellen K Tremellen K Oxidative stress and male infertility - a clinical
perspective
Repromed & University of
Adelaide
Australia
10 45 Rosen RC Giuliano F Lower urinary tract symptoms and male
sexual dysfunction: The multinational survey
of the aging male (MSAM-7)
Robert Wood Johnson Medical
School
USA
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with less emphasis on provision of ‘core urological’ ser-
vices, therefore potentially allowing more time for aca-
demic pursuits. This geographical dominance has also
been observed in other bibliometric analyses [7] and
may also be explained by differences in academic focus
in relation to clinical practice, with more funding pro-
vided to clinicians’ academic work in the USA compared
to elsewhere, which in turn appears to correlate with a
higher quality of research [33].
It is important to note that only two manuscripts
within the top 100 focus on the management of penile
cancer (Maden, ranked 79 [34] and Daling, ranked 98
[35]). This is the only cancer that is commonly managed
by andrologists and therefore one would expect to see a
greater number of manuscripts related to its pathophysi-
ology, treatment and follow-up within the top 100.
However, it is likely that the low incidence of this condi-
tion makes it a relative ‘Cinderella’ subspecialty within
the field and therefore papers focussed on penile cancer
are less widely cited when compared to the much more
commonly encountered conditions of ED and hypo-
gonadism [36]. Moreover, due to the paucity of cases
seen in routine practice it is difficult to establish a
cohort of sufficient size for high quality observational or
interventional research. This, coupled with the known
difficulties in conducting high quality surgical trials [37],
means that manuscripts are often of low levels of evi-
dence, thus precluding them from publication in high
impact factor journals.
The journals in which the top 100 manuscripts were
published varied significantly both in theme and impact
factor. The latter was particularly varied and ranged
from 72.406 to 1.293 (median 5.5025). Interestingly, im-
pact factor did not necessarily correlate with the most
cited papers. For example, the second most cited paper
by Rosen, et al. [16] was published in ‘Urology’, which
was the sixth-lowest ranked journal in terms of im-
pact factor within this analysis (2.309). One explan-
ation for this variation is the multidisciplinary nature
of many conditions encountered under the umbrella
of andrology. Furthermore, the subspecialised nature
of many andrological conditions means that manu-
scripts pertaining to these topics are often not
directly relevant to ‘core’ clinical practice and are
therefore less likely to be published in higher impact
factor journals that seek to meet the interests of a
broad audience.
The main limitation of bibliometric analysis is the po-
tential for a number of types of bias. Firstly, dispropor-
tionate citation may result from institutional bias,
language biases, self-citation or powerful person bias. In
addition, older manuscripts may receive more citations
due to the length of time in which they are in the public
domain. Although the use of citation rate attempts to
control for this, it may take a number of years for influ-
ential manuscripts to accrue citations due to the publi-
cation lead-time for their citing manuscript. A further
limitation is the inclusion of only first and senior au-
thors, and the institution of the first author. It is possible
that several first authors will have co-authored other pa-
pers in the top 100 and therefore be underrepresented
in the current study. Finally, searching based on title
means a small number of manuscripts that have key
andrological themes without pertaining to these in their
title may not have been identified.
Conclusion
This list of highly cited papers identifies the topics
and authors that have made the most impact in the
discipline of andrology over the last century. There is
a clear predominance of manuscripts focusing on the
treatment and pathophysiology of ED, which should
therefore be considered the most widely researched,
published and cited field within andrological practice.
This study provides a reference of what may be
considered as the most influential papers in androl-
ogy and serves as a inidcation of what comprises a
‘highly citable’ manuscript for both researchers and
clinicians.
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